HC Wainwright Decreases Earnings Estimates for Urogen Pharma
Urogen Pharma (NASDAQ:URGN – Free Report) – Stock analysts at HC Wainwright lowered their Q2 2025 earnings per share estimates for shares of Urogen Pharma in a report issued on Monday, June 16th. HC Wainwright analyst R. Selvaraju now expects that the company will earn ($0.80) per share for the quarter, down from their previous […]
Urogen Pharma (NASDAQ:URGN – Free Report) – Stock analysts at HC Wainwright lowered their Q2 2025 earnings per share estimates for shares of Urogen Pharma in a report issued on Monday, June 16th. HC Wainwright analyst R. Selvaraju now expects that the company will earn ($0.80) per share for the quarter, down from their previous […]
